Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi




http://scihub22266oqcxt.onion/
suck pdf from google scholar
2657056!ä!2657056

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid2657056      J+Hum+Hypertens 1989 ; 3 (1): 29-33
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Twice-daily low-dose captopril in diuretic-treated hypertensives #MMPMID2657056
  • Murdoch DL; Gillen GJ; Morton JJ; Leckie B; Murray GD; Davies DL; McInnes GT
  • J Hum Hypertens 1989[Feb]; 3 (1): 29-33 PMID2657056show ga
  • Twice-daily captopril (25 mg) and placebo were compared in ten hypertensive patients who were already receiving bendrofluazide. After six weeks therapy, captopril produced significant antihypertensive effects one to six hours after dosing but these did not persist at eleven to twelve hours. Plasma renin concentration was increased for twelve hours after captopril but inhibition of angiotensin II activity was lost by twelve hours. During the period when captopril reduced blood pressure significantly, effective renal plasma flow and hepatic blood flow were unchanged although renal vascular resistance was reduced. There was no evidence that captopril altered plasma sodium, potassium or magnesium concentrations following bendrofluazide. Thus, in thiazide-treated patients, captopril 25 mg produces significant blood pressure reduction for at least six hours after dosing, without impairing renal or hepatic blood flow. However, twice-daily low-dose captopril does not adequately control blood pressure throughout the dosage interval.
  • |*Benzothiadiazines[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Angiotensin II/blood[MESH]
  • |Captopril/*administration & dosage/adverse effects/pharmacology[MESH]
  • |Diuretics[MESH]
  • |Drug Evaluation[MESH]
  • |Drug Therapy, Combination[MESH]
  • |Female[MESH]
  • |Hemodynamics/drug effects[MESH]
  • |Humans[MESH]
  • |Hypertension/*drug therapy[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Renin/blood[MESH]
  • |Sodium Chloride Symporter Inhibitors/administration & dosage/*pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box